α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability
about
Use of rodents as models of human diseasesGMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.
P2860
α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability
description
im Februar 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2012
@uk
name
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@en
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@nl
type
label
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@en
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@nl
prefLabel
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@en
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@nl
P2093
P2860
P356
P1476
α-Tocopheryloxyacetic acid is ...... as due to its higher stability
@en
P2093
Emmanuel Akporiaye
Helen Massa
Lan-Feng Dong
Renata Zobalova
P2860
P304
P356
10.1002/IJC.26489
P577
2012-02-09T00:00:00Z